Annual EBIT:
-$285.42M-$112.55M(-65.11%)Summary
- As of today, AKRO annual earnings before interest & taxes is -$285.42 million, with the most recent change of -$112.55 million (-65.11%) on December 31, 2024.
- During the last 3 years, AKRO annual EBIT has fallen by -$184.54 million (-182.92%).
- AKRO annual EBIT is now -6153.79% below its all-time high of -$4.56 million, reached on December 31, 2017.
Performance
AKRO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$80.87M+$9000.00(+0.01%)Summary
- As of today, AKRO quarterly earnings before interest & taxes is -$80.87 million, with the most recent change of +$9000.00 (+0.01%) on June 30, 2025.
- Over the past year, AKRO quarterly EBIT has dropped by -$15.13 million (-23.02%).
- AKRO quarterly EBIT is now -19109.74% below its all-time high of -$421.00 thousand, reached on March 31, 2018.
Performance
AKRO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$321.48M-$15.13M(-4.94%)Summary
- As of today, AKRO TTM earnings before interest & taxes is -$321.48 million, with the most recent change of -$15.13 million (-4.94%) on June 30, 2025.
- Over the past year, AKRO TTM EBIT has dropped by -$87.30 million (-37.28%).
- AKRO TTM EBIT is now -58887.71% below its all-time high of -$545.00 thousand, reached on December 1, 2017.
Performance
AKRO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
AKRO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -65.1% | -23.0% | -37.3% |
| 3Y3 Years | -182.9% | -193.1% | -191.1% |
| 5Y5 Years | -525.6% | -391.5% | -382.9% |
AKRO EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -182.9% | at low | -218.2% | +1.0% | -179.2% | at low |
| 5Y | 5-Year | -525.6% | at low | -434.6% | +1.0% | -382.9% | at low |
| All-Time | All-Time | -6153.8% | at low | >-9999.0% | +1.0% | >-9999.0% | at low |
AKRO EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$80.87M(+0.0%) | -$321.48M(-4.9%) |
| Mar 2025 | - | -$80.88M(-3.7%) | -$306.35M(-7.3%) |
| Dec 2024 | -$285.42M(-65.1%) | -$78.03M(+4.5%) | -$285.42M(-6.0%) |
| Sep 2024 | - | -$81.70M(-24.3%) | -$269.27M(-15.0%) |
| Jun 2024 | - | -$65.74M(-9.7%) | -$234.18M(-14.8%) |
| Mar 2024 | - | -$59.95M(+3.1%) | -$204.07M(-18.0%) |
| Dec 2023 | -$172.87M(-50.1%) | -$61.87M(-32.7%) | -$172.87M(-26.7%) |
| Sep 2023 | - | -$46.62M(-30.8%) | -$136.42M(-8.4%) |
| Jun 2023 | - | -$35.63M(-23.9%) | -$125.89M(-6.8%) |
| Mar 2023 | - | -$28.75M(-13.1%) | -$117.86M(-2.3%) |
| Dec 2022 | -$115.16M(-14.1%) | -$25.42M(+29.6%) | -$115.16M(+5.7%) |
| Sep 2022 | - | -$36.09M(-30.8%) | -$122.17M(-10.6%) |
| Jun 2022 | - | -$27.59M(-5.9%) | -$110.44M(+1.2%) |
| Mar 2022 | - | -$26.05M(+19.7%) | -$111.81M(-10.8%) |
| Dec 2021 | -$100.89M | -$32.44M(-33.2%) | -$100.89M(-2.7%) |
| Sep 2021 | - | -$24.35M(+15.9%) | -$98.23M(-3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$28.97M(-91.5%) | -$95.42M(-15.1%) |
| Mar 2021 | - | -$15.13M(+49.2%) | -$82.90M(-3.4%) |
| Dec 2020 | -$80.15M(-75.7%) | -$29.78M(-38.3%) | -$80.15M(-20.4%) |
| Sep 2020 | - | -$21.54M(-30.9%) | -$66.57M(-8.5%) |
| Jun 2020 | - | -$16.45M(-32.9%) | -$61.34M(-16.8%) |
| Mar 2020 | - | -$12.38M(+23.6%) | -$52.49M(-15.1%) |
| Dec 2019 | -$45.63M(-231.2%) | -$16.20M(+0.7%) | -$45.63M(-40.8%) |
| Sep 2019 | - | -$16.31M(-114.3%) | -$32.40M(-81.8%) |
| Jun 2019 | - | -$7.61M(-38.0%) | -$17.82M(+5.6%) |
| Mar 2019 | - | -$5.51M(-85.7%) | -$18.87M(-37.0%) |
| Dec 2018 | -$13.78M(-201.9%) | -$2.97M(-71.9%) | -$13.78M(-21.3%) |
| Sep 2018 | - | -$1.73M(+80.1%) | -$11.36M(-17.9%) |
| Jun 2018 | - | -$8.66M(-1957.5%) | -$9.63M(-896.7%) |
| Mar 2018 | - | -$421.00K(+22.8%) | -$966.00K(-77.2%) |
| Dec 2017 | -$4.56M | - | - |
| Dec 2017 | - | -$545.00K | -$545.00K |
FAQ
- What is Akero Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. annual EBIT year-on-year change?
- What is Akero Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Akero Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. TTM EBIT year-on-year change?
What is Akero Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of AKRO is -$285.42M
What is the all-time high annual EBIT for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$4.56M
What is Akero Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, AKRO annual earnings before interest & taxes has changed by -$112.55M (-65.11%)
What is Akero Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of AKRO is -$80.87M
What is the all-time high quarterly EBIT for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is -$421.00K
What is Akero Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, AKRO quarterly earnings before interest & taxes has changed by -$15.13M (-23.02%)
What is Akero Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of AKRO is -$321.48M
What is the all-time high TTM EBIT for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$545.00K
What is Akero Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, AKRO TTM earnings before interest & taxes has changed by -$87.30M (-37.28%)